What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review

ABSTRACT

Radiotherapy treatment continues to have a relevant impact in the treatment of nonsmall cell cancer (NSCLC). Use of concurrent chemotherapy and radiotherapy is considered the gold standard in the treatment of locally advanced NSCLC but clinical outcomes are not satisfactory. Introduction of new radiotherapy technology and chemotherapy regimens are under investigation in this setting with the goal to improve unsatisfactory results. We report how radiotherapy is changing in the treatment of locally advanced NSCLC.

KEYWORDS:

• Radiotherapy
• Non small cell lung cancer
• Locally advanced
• Altered fractionation
• Dose escalation
• New technology

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.